Biomarkers are increaingly being used in the management of heart failure not only for the purpose of screening, diagnosis, and risk stratification, but also as a guide to evaluate the response to treatment in the individual patient and as an entry criterion and/or a surrogate marker of efficacy in clinical trials testing novel drugs. In this chapter, we review the role of established biomarkers for heart failure management, according to the main classification of HF phenotypes, based on the measurement of left ventricular ejection fraction, including heart failure with reduced (<40%), preserved (≥50%), and, as recently proposed, mid-range (40-49%) ejection fraction.

Senni, M., D'Elia, E., Emdin, M., Vergaro, G. (2017). Biomarkers of heart failure with preserved and reduced ejection fraction. In J. Bauersachs, J. Butler, P. Sandner (a cura di), Heart Failure (pp. 79-108). New York : Springer [10.1007/164_2016_86].

Biomarkers of heart failure with preserved and reduced ejection fraction

Senni M.;
2017

Abstract

Biomarkers are increaingly being used in the management of heart failure not only for the purpose of screening, diagnosis, and risk stratification, but also as a guide to evaluate the response to treatment in the individual patient and as an entry criterion and/or a surrogate marker of efficacy in clinical trials testing novel drugs. In this chapter, we review the role of established biomarkers for heart failure management, according to the main classification of HF phenotypes, based on the measurement of left ventricular ejection fraction, including heart failure with reduced (<40%), preserved (≥50%), and, as recently proposed, mid-range (40-49%) ejection fraction.
Recensione in volume
Biomarkers; Diagnosis; Heart failure management; Prognosis; Screening
English
Heart Failure
978-3319596587
Senni, M., D'Elia, E., Emdin, M., Vergaro, G. (2017). Biomarkers of heart failure with preserved and reduced ejection fraction. In J. Bauersachs, J. Butler, P. Sandner (a cura di), Heart Failure (pp. 79-108). New York : Springer [10.1007/164_2016_86].
Senni, M; D'Elia, E; Emdin, M; Vergaro, G
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/372449
Citazioni
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 6
Social impact